Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

Abbreviated New Drug Application (ANDA): 213181
Company: AJANTA PHARMA LTD
Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status TE Code RLD RS
DIVALPROEX SODIUM DIVALPROEX SODIUM EQ 125MG VALPROIC ACID CAPSULE, DELAYED REL PELLETS;ORAL Prescription AB No No
Original Approvals or Tentative Approvals
Action Date Submission Action Type Submission Classification Review Priority; Orphan Status Letters, Reviews, Labels, Patient Package Insert Notes Url
02/28/2020 ORIG-1 Approval STANDARD

Label is not available on this site.

DIVALPROEX SODIUM

CAPSULE, DELAYED REL PELLETS;ORAL; EQ 125MG VALPROIC ACID
TE Code = AB

Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status RLD TE Code Application No. Company
DEPAKOTE DIVALPROEX SODIUM EQ 125MG VALPROIC ACID CAPSULE, DELAYED REL PELLETS;ORAL Prescription Yes AB 019680 ABBVIE
DIVALPROEX SODIUM DIVALPROEX SODIUM EQ 125MG VALPROIC ACID CAPSULE, DELAYED REL PELLETS;ORAL Prescription No AB 213181 AJANTA PHARMA LTD
DIVALPROEX SODIUM DIVALPROEX SODIUM EQ 125MG VALPROIC ACID CAPSULE, DELAYED REL PELLETS;ORAL Prescription No AB 078979 DR REDDYS LABS LTD
DIVALPROEX SODIUM DIVALPROEX SODIUM EQ 125MG VALPROIC ACID CAPSULE, DELAYED REL PELLETS;ORAL Prescription No AB 078919 ZYDUS PHARMS USA INC

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English